{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T21:19:59Z","timestamp":1768425599774,"version":"3.49.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.intimp.2022.109579","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T10:12:05Z","timestamp":1672049525000},"page":"109579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Low-dose decitabine for refractory thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children: A pilot study"],"prefix":"10.1016","volume":"115","author":[{"given":"Nan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen-Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ping","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.109579_b0005","first-page":"151","article-title":"Plasma levels of norepinephrine and expression levels of ss2-adrenergic receptor gene correlate with the incidence of acute graft-versus-host disease","volume":"34","author":"Momeni-Varposhti","year":"2020","journal-title":"Med. J. Islam Repub. Iran"},{"issue":"3","key":"10.1016\/j.intimp.2022.109579_b0010","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/bbmt.2001.v7.pm11302549","article-title":"Secondary failure of platelet recovery after hematopoietic stem cell transplantation","volume":"7","author":"Bruno","year":"2001","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.intimp.2022.109579_b0015","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood.V65.2.368.368","article-title":"Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes","volume":"65","author":"First","year":"1985","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.intimp.2022.109579_b0020","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1182\/blood.V91.9.3509","article-title":"A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation","volume":"91","author":"Bernstein","year":"1998","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.intimp.2022.109579_b0025","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.22086","article-title":"Prognostic significance of delayed thrombocytopenia after allogeneic stem cell transplant","volume":"86","author":"Zaja","year":"2011","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109579_b0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2141.2001.02468.x","article-title":"Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose","volume":"112","author":"Dominietto","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109579_b0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/sj.bmt.1705444","article-title":"Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover","volume":"38","author":"Yamazaki","year":"2006","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.intimp.2022.109579_b0040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jamaoncol.2014.316","article-title":"Low-Dose Decitabine for Patients With Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation: A Pilot Therapeutic Study","volume":"1","author":"Han","year":"2015","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109579_b0045","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1182\/bloodadvances.2020002790","article-title":"Low-dose decitabine for refractory prolonged isolated thrombocytopenia after HCT: a randomized multicenter trial","volume":"5","author":"Tang","year":"2021","journal-title":"Blood Adv."},{"issue":"8","key":"10.1016\/j.intimp.2022.109579_b0050","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.leukres.2003.11.016","article-title":"The effects of 5-aza-2'-deoxycytidine (Decitabine) on the platelet count in patients with intermediate and high-risk myelodysplastic syndromes","volume":"28","author":"van den Bosch","year":"2004","journal-title":"Leuk. Res."},{"issue":"12","key":"10.1016\/j.intimp.2022.109579_b0055","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/ajh.25646","article-title":"A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia","volume":"94","author":"Zhou","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109579_b0060","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.2020008477","article-title":"Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia","volume":"138","author":"Han","year":"2021","journal-title":"Blood"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922010645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922010645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T13:03:02Z","timestamp":1736427782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922010645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":12,"alternative-id":["S1567576922010645"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109579","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose decitabine for refractory thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children: A pilot study","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109579"}}